72 related articles for article (PubMed ID: 9029495)
21. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
22. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Doucet E; Hamon M; Bruni G; Romeo MR; Menziani MC; De Benedetti PG; Langer T
J Med Chem; 1998 Feb; 41(5):728-41. PubMed ID: 9513601
[TBL] [Abstract][Full Text] [Related]
23. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
24. Native serotonin 5-HT3 receptors expressed in Xenopus oocytes differ from homopentameric 5-HT3 receptors.
van Hooft JA; Kreikamp AP; Vijverberg HP
J Neurochem; 1997 Sep; 69(3):1318-21. PubMed ID: 9282959
[TBL] [Abstract][Full Text] [Related]
25. Tetraethylammonium ions block 5-HT3 receptor-mediated ion current at the agonist recognition site and prevent desensitization in cultured mouse neuroblastoma cells.
Kooyman AR; Zwart R; Vijverberg HP
Eur J Pharmacol; 1993 Aug; 246(3):247-54. PubMed ID: 7693498
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of the membrane current mediated by serotonin 5-HT3 receptors in cultured mouse neuroblastoma cells.
Neijt HC; Plomp JJ; Vijverberg HP
J Physiol; 1989 Apr; 411():257-69. PubMed ID: 2482354
[TBL] [Abstract][Full Text] [Related]
27. 5-HT3 receptors in outside-out patches of N1E-115 neuroblastoma cells: basic properties and effects of pentobarbital.
Barann M; Göthert M; Bönisch H; Dybek A; Urban BW
Neuropharmacology; 1997; 36(4-5):655-64. PubMed ID: 9225291
[TBL] [Abstract][Full Text] [Related]
28. Identification of a domain affecting agonist potency of meta-chlorophenylbiguanide in 5-HT3 receptors.
Mochizuki S; Miyake A; Furuichi K
Eur J Pharmacol; 1999 Mar; 369(1):125-32. PubMed ID: 10204690
[TBL] [Abstract][Full Text] [Related]
29. Competitive and non-competitive effects of 5-hydroxyindole on 5-HT3 receptors in N1E-115 neuroblastoma cells.
Kooyman AR; van Hooft JA; Vanderheijden PM; Vijverberg HP
Br J Pharmacol; 1994 Jun; 112(2):541-6. PubMed ID: 8075873
[TBL] [Abstract][Full Text] [Related]
30. Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors.
Morton RA; Baptista-Hon DT; Hales TG; Lovinger DM
Br J Pharmacol; 2015 Aug; 172(16):4066-77. PubMed ID: 25989383
[TBL] [Abstract][Full Text] [Related]
31. RS-056812-198: partial agonist on native and antagonist on cloned 5-HT3 receptors.
Van Hooft JA; Vijverberg HP
Eur J Pharmacol; 1997 Mar; 322(2-3):229-33. PubMed ID: 9098692
[TBL] [Abstract][Full Text] [Related]
32. Radioligand binding and photoaffinity labelling studies show a direct interaction of phenothiazines at 5-HT3 receptors.
Lummis SC; Baker J
Neuropharmacology; 1997; 36(4-5):665-70. PubMed ID: 9225292
[TBL] [Abstract][Full Text] [Related]
33. 5-Hydroxyindole slows desensitization of the 5-HT3 receptor-mediated ion current in N1E-115 neuroblastoma cells.
Kooyman AR; van Hooft JA; Vijverberg HP
Br J Pharmacol; 1993 Feb; 108(2):287-9. PubMed ID: 7680589
[TBL] [Abstract][Full Text] [Related]
34. Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors.
Hussy N; Lukas W; Jones KA
J Physiol; 1994 Dec; 481 ( Pt 2)(Pt 2):311-23. PubMed ID: 7537814
[TBL] [Abstract][Full Text] [Related]
35. 5-HT3 receptors induce rises in cytosolic and nuclear calcium in NG108-15 cells via calcium-induced calcium release.
Rondé P; Nichols RA
Cell Calcium; 1997 Nov; 22(5):357-65. PubMed ID: 9448942
[TBL] [Abstract][Full Text] [Related]
36. Allosteric potentiation of the 5-HT3 receptor-mediated ion current in N1E-115 neuroblastoma cells by 5-hydroxyindole and analogues.
van Hooft JA; van der Haar E; Vijverberg HP
Neuropharmacology; 1997; 36(4-5):649-53. PubMed ID: 9225290
[TBL] [Abstract][Full Text] [Related]
37. Allosteric activation of the 5-HT3AB receptor by mCPBG.
Miles TF; Lester HA; Dougherty DA
Neuropharmacology; 2015 Apr; 91():103-8. PubMed ID: 25541413
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of NG108-15 cells alters channel conductance and desensitization kinetics of the 5-HT3 receptor.
Shao XM; Yakel JL; Jackson MB
J Neurophysiol; 1991 Mar; 65(3):630-8. PubMed ID: 1711105
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of serotonin and dopamine on human 5-HT3A receptor kinetics: interpretation within an allosteric kinetic model.
Solt K; Ruesch D; Forman SA; Davies PA; Raines DE
J Neurosci; 2007 Nov; 27(48):13151-60. PubMed ID: 18045909
[TBL] [Abstract][Full Text] [Related]
40. Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor.
Hapfelmeier G; Tredt C; Haseneder R; Zieglgänsberger W; Eisensamer B; Rupprecht R; Rammes G
Biophys J; 2003 Mar; 84(3):1720-33. PubMed ID: 12609874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
